rare disease | infill

And the winner is….

1 February 20171 April 2019 by Anna Hermann

Anna Hermann

3767

Pharmaceutical Market Excellence Awards, Winner Category: "Rare Diseases and Orphan Drugs" For the IPF Digital Initiative – a combination of several customer and patient-centric education and support programmes developed by infill healthcare communication for Boehringer Ingelheim GmbH. Judges' comment: “Boehringer Ingelheim carried out detailed research into…

Mastering the rare disease challenge

15 July 201618 May 2018 by Anna Hermann

Anna Hermann

2871

Orphan drugs are few and far between. Long awaited by patients and physicians it should be an easy job to market them. However, diagnosis comes before treatment and with more than 6,000 rare diseases prevalent in Europe alone, it is little surprising that physicians are vague on specifics. Clinicians have…